期刊文献+

泰拉霉素和红霉素对一氧化氮和前列腺素E2合成抑制作用的比较 被引量:3

In vitro Inhibitory Effects of Tulathromycin and Erythromycin on the Productions of NO and PGE_2
下载PDF
导出
摘要 目的以红霉素为对照,探讨泰拉霉素是否具有抗炎作用。方法利用细菌脂多糖(LPS)诱导猪外周血单核细胞(PBMC)过度表达致炎因子而构建的体外炎症模型,采用SYBR Green法实时荧光定量PCR技术,在分子水平研究了不同浓度泰拉霉素和红霉素对一氧化氮(NO)和前列腺素E2(PGE2)合成的影响。结果20μg·mL-1和10μg·mL-1浓度的泰拉霉素与20、10和5μg·mL-1浓度的红霉素均能显著抑制猪PBMC细胞合成NO和PGE2,并抑制诱导型一氧化氮合成酶(iNOS)和环氧合酶-2(COX-2)基因的转录;而5μg·mL-1的泰拉霉素无明显的这种调节作用。结论泰拉霉素和红霉素能在转录和翻译水平通过调节致炎因子的合成而发挥抗炎作用。 Objective The anti-inflammatory effects of tulathromycin were studied. Method In vitro, we make use of the model that is LPS-induced porcine peripheral blood mononuclear cells (PBMC) overexpressing pro-inflammation factors was used, and then the real-time Q-PCR was employed to study the effect of different concentrations of tulathromycin and erythromycin on the generation of NO and PGE2 involved in the inflammatory process on the molecular level. Result Results showed that tulathromycin at the concentrations of 5, 10 and 20 μg·mL-1 significantly decreased the production of NO and PGE2, a similar pattern was also observed on the cyclooxygenase (COX-2) and inducible nitric oxide synthase (iNOS) gene transcription. However, all 5, 10 and 20 μg·mL-1 of erythromycin significantly decreased the production of NO and PGE2 on the transcription and expression level. Conclusion These results support the opinion that macrolides may exert anti-inflammatory effect through modulating the synthesis of NO and PGE2 in inflammatory process.
出处 《中国农业科学》 CAS CSCD 北大核心 2010年第9期1939-1947,共9页 Scientia Agricultura Sinica
基金 教育部《长江学者和创新团队发展计划》创新团队项目(IRTO848)
关键词 泰拉霉素 红霉素 一氧化氮 前列腺素E2 诱导型一氧化氮合成酶 环氧合酶-2 tulathromycin erythromycin NO PGE2 iNOS COX-2
  • 相关文献

参考文献38

  • 1Nutsch R G, Hart F J, Rooney K A, Weigel D J, Randal K W, Skogerboe T L. Efficacy of tulathromycin injectable solution for the treatment of naturally occurring swine respiratory disease. Veterinary Therapeutics, 2005, 6(2): 214-224.
  • 2Godinho K S, Wolf R M, Sherington J, Rowan T G, Sunderland S J, Evans N A. Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle. Veterinary Therapeutics, 2005, 6(2): 122-135.
  • 3Nowakowski M A, Inskeep P B, Risk J E, Skogerboe T L, Benchaoui H A, Meinert T R, Sherington J, Sunderland S J. Pbarmacokinetics and lung tissue concentrations of tulatbromycin, a new triamilide antibiotic, in cattle. Veterinary Therapeutics, 2004, 5(1): 60-74.
  • 4Benchaoui H A, Nowakowski M A, Sherington J, Rowan T G, Sunderland S J. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. Journal of Veterinary Pharmacology & Therapeutics, 2004, 27(4): 203-210.
  • 5Godinho K S, Rae A, Windsor G D, Tilt N, Rowan T G, Sunderland S J. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves. Veterinary Therapeutics, 2005, 6(2): 96-112.
  • 6Chin A C, Morck D W, Merrill J K, Ceil H, Olson M E, Read R R, Dick P, Buret A G. Anti-inflammatory benefits of filmicosin in calves with Pasteurella haemolytica-infected lungs. American Journal of Veterinary Research, 1998, 59:765-771.
  • 7Crystal C K, David J E, Alex C C, Merle E O, Ronald R R, Howard C, Douglas W M, Andre G B. Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy, 2000, 46:19-26.
  • 8Chin A C, Lee W D, Murrin K A, Morck D W, Merrill J K, Dick P, Buret A G. Tilrnicosin induces apoptosis in bovine peripheral neutrophils in the presence or in the absence of Pasteurella haemolytica and promotes neutrophil phagocytosis by macrophages. Antimicrobial Agents Chemotherapy, 2000, 44: 2465-2470.
  • 9Lee W D, Flynn A N, LeBlanc J M, Merrill J K, Dick P, Morck D W, Buret A G. Tilmicosin-induced bovine neutrophil apoptosis is cell-specific and downregulates spontaneous LTB4 synthesis without increasing Fas expression. Veterinary Research, 2004, 35: 213-224.
  • 10Lakritz J. Tilmicosin reduces lipopolysaccharide stimulated bovine alveolar macrophage prostaglandin E2 production via a mechanism involving phospholipases. Veterinary Therapeutics, 2002, 3: 7-21.

同被引文献36

  • 1蔡巍,陈君柱,阮黎明,王懿娜.Effects of fructose-1,6-diphosphate on concentration of calcium and activities of sarcoplosnic Ca^(2+)-ATPase in cardiomyocytes of Adriamycin-treated rats[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2005,6(7):622-625. 被引量:9
  • 2EMA. Scientific discussions[EB/OL]. [2008-05-04].http://www. ema. europa. eu/docs/en GB/documentlibrary/ EPAR-Scientific Discussion/ veterinary/000129/WC500068716. pdf.
  • 3Zita M,Antonio H. Carlos method of synthesizingmacrolide compounds[J]. 2009,10(23) : 2010.
  • 4Mitchell J D, Goh S,McKellar Q A,et al. In vitropharmacodynamics of gamithromycin against Myco-plasma mycoides subspecies mycoides small colony[J]. Vet 1,2013,197(3):806-811.
  • 5Berghaus L J,Giguere S,Sturgill T L. et al. Plasmapharmacokinetics,pulmonary distribution, and invitro activity of gamithromycin in foals [J]. J VetPharmacol Ther,2012,35(1) :59-66.
  • 6Wyns H.Meyer E,Plessers E,et al. Pharmacokineticsof gamithromycin after intravenous and subcutaneousadministration in pigs[J]. Res Vet Sci, 2014,96(1):160-163.
  • 7Forbes A B,Ramage C,Sales J,et al. Determination oftheduration of antibacterial efficacy following admin-istration of gamithromycin using a bovine mannheimiahaemolytica challenge model [J]. Antimicrob AgentsChem,2011,55(2)-831-835.
  • 8Lechtenberg K,Tessman R K.Romano D. Efficacy of-gamithromycin injectable solution for control of pneu-monia in cattle challenged with histophilus somni af-ter treatment[J]. Int J App Res Vet Med,2011,9(3):.214-248.
  • 9Lechtenberg K F,Scanlon Daniels C, Schieber T, etal. Field efficacy study of gamithromycin for the treat-ment of bovine respiratory disease associated withmycoplasma bo vis in beef and non-lactating dairy cat-tle[J]. Int J Appl Res Vet Med,2011,9(3) :225-232.
  • 10Lechtenberg K,Tessman R K,Theodore C S. Efficacyof gamithromycin injectable solution for the treatmentof mycoplasma bovis induced pneumonia in cattle[J].Int J Appl Res Vet Med,2011,9(3) :233-240.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部